Literature DB >> 35106491

Multiple Cardiac Calcified Amorphous Tumors.

Yuto Suetani1, Yoh Arita1, Kenji Tanaka2, Masako Okada3, Nobuyuki Ogasawara1.   

Abstract

A 61-year-old woman who underwent hemodialysis presented with heart failure. Echocardiography revealed multiple mobile masses in the left atrium. The masses were excised, and histopathologic examination revealed calcified amorphous tumors. Here, we present several echocardiography images, including 3-dimensional transesophageal echocardiography, demonstrating the revolving masses in the left atrium. (Level of Difficulty: Intermediate.).
© 2022 The Authors.

Entities:  

Keywords:  CAT, calcified amorphous tumor; CRP, C-reactive protein; IE, infective endocarditis; MR, mitral regurgitation; MS, mitral stenosis; NYHA, New York Heart Association; TTE, transthoracic echocardiography; calcified amorphous tumor; echocardiography; heart failure; infective endocarditis

Year:  2022        PMID: 35106491      PMCID: PMC8784721          DOI: 10.1016/j.jaccas.2021.08.018

Source DB:  PubMed          Journal:  JACC Case Rep        ISSN: 2666-0849


Case Presentation

A 61-year-old woman undergoing hemodialysis for 6 years was hospitalized in a referral hospital for infected ulceration of the lower limbs. Because transthoracic echocardiography (TTE) revealed mobile masses suggestive of infective endocarditis (IE), she was transferred to our hospital (Japan Community Healthcare Organization Osaka Hospital, Osaka, Japan). On admission, she presented with New York Heart Association (NYHA) functional class III heart failure and needed hemodialysis using nafamostat mesylate without clinically problematic arrhythmias, stroke, and transient ischemic attack. Her laboratory examination showed a C-reactive protein (CRP) level of 6.58 mg/dL (normal range 0-0.14 mg/dL), procalcitonin of 0.68 ng/mL (normal range 0-0.5 mg/mL), and an estimated glomerular filtration rate of 7.8 mL/min/1.73 m2. The platelet count, prothrombin time, activated partial thromboplastin time, and prothrombin time–international normalized ratio were within a normal range. Chest radiography revealed cardiomegaly and pulmonary congestion. TTE revealed severe mitral regurgitation (MR) (maximal MR jet area / left atrium area = 47%), moderate mitral stenosis (MS) (1.47 cm2 by planimetry methods), moderate aortic stenosis (mean pressure gradient 32 mm Hg). and moderate tricuspid regurgitation (peak pressure gradient 54 mm Hg) with pulmonary hypertension (Figure 1A, Video 1). Transesophageal echocardiography demonstrated 3 mobile masses in the left atrium (Figure 1B, Video 2). Two of the 3 masses were located in the posterior mitral annulus, and the other mass was attached to the mitral valve posterior leaflet accompanied by severe MR (Figure 1C, Video 3). Abdominal computed tomography revealed splenic infarction as a part of systemic embolism. The masses were excised during emergency surgery. Aortic and mitral valve replacements were also performed. Pathologic examination of the excised masses revealed calcification and fibrous degeneration (Figure 1D). No inflammatory or malignant cells were observed. These findings confirmed the diagnosis of calcified amorphous tumors (CATs). Postoperatively, the patient’s symptoms improved to NYHA functional class I. However, the patient had progressive leg ulceration and underwent leg amputation.
Figure 1

Cardiac Calcified Amorphous Tumor

(A) Transthoracic echocardiography (parasternal long-axis view) shows a mobile mass attached to the left atrium (arrow). (B) A 3-dimensional transesophageal echocardiography image shows mobile masses in the left atrium (arrows). (C) Transesophageal echocardiography shows severe mitral regurgitation. (D) Hematoxylin and eosin staining of the excised masses shows dense calcification and fibrous degeneration (magnification ×20). Ao = aorta; AV = aortic valve; LA = left atrium; LAA = left atrial appendage; LV = left ventricle; MV = mitral valve.

Cardiac Calcified Amorphous Tumor (A) Transthoracic echocardiography (parasternal long-axis view) shows a mobile mass attached to the left atrium (arrow). (B) A 3-dimensional transesophageal echocardiography image shows mobile masses in the left atrium (arrows). (C) Transesophageal echocardiography shows severe mitral regurgitation. (D) Hematoxylin and eosin staining of the excised masses shows dense calcification and fibrous degeneration (magnification ×20). Ao = aorta; AV = aortic valve; LA = left atrium; LAA = left atrial appendage; LV = left ventricle; MV = mitral valve. Cardiac CATs, often reported in patients with end-stage renal disease or undergoing hemodialysis, are described as non-neoplastic masses characterized by nodular calcification in the background of degenerating blood elements and chronic inflammation (1). CATs have been found in all cardiac chambers. However, mobile CATs indicate an impending risk for stroke or other systemic embolism and should be regarded as distinct from immobile CATs (2). In addition, mobile CATs can interfere with blood flow through the mitral valve, as in our case. The mean pressure gradient of the mitral valve was 15 mm Hg, which could be considered severe MS, but the valve area was 1.47 cm2, indicating moderate MS. Cardiac CATs accompanied by IE have also been reported (3). However, our patient did not present with typical symptoms such as Osler nodes, Janeway lesions, and conjunctival hemorrhages. The blood culture results for bacterial infection were negative, and the evidence of IE was not obtained by pathologic examination. Therefore, the possibility of cardiac CAT accompanied by IE was excluded in our case. The elevated CRP level was considered to be caused by the infection in the lower limbs. In conclusion, CATs cannot be diagnosed using imaging modalities alone. The final diagnosis is made on the basis of pathologic examination.

Funding Support and Author Disclosures

The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
  3 in total

1.  Cardiac swinging calcified amorphous tumors in end-stage renal failure patients.

Authors:  Hiroshi Kubota; Yasunori Fujioka; Hideaki Yoshino; Hitoshi Koji; Ken Yoshihara; Kunihiko Tonari; Hidehito Endo; Hiroshi Tsuchiya; Hisaaki Mera; Yukiko Soga; Seiichi Taniai; Konomi Sakata; Kenichi Sudo
Journal:  Ann Thorac Surg       Date:  2010-11       Impact factor: 4.330

2.  A Case of Cardiac Calcified Amorphous Tumor Presenting with Concomitant ST-Elevation Myocardial Infarction and Occipital Stroke and a Brief Review of the Literature.

Authors:  Kyaw Kyaw; Htun Latt; Sammy San Myint Aung; Chanwit Roongsritong
Journal:  Case Rep Cardiol       Date:  2017-12-24

Review 3.  The First Report of Calcified Amorphous Tumor Associated with Infective Endocarditis: A Case Report and Review of Literature.

Authors:  Aiko Okazaki; Yu Oyama; Naoto Hosokawa; Hirokazu Ban; Yasutomo Miyaji; Sandra Moody
Journal:  Am J Case Rep       Date:  2020-05-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.